Tempol-nebivolol therapy potentiates hypotensive effect increasing NO bioavailability and signaling pathway. [electronic resource]
Producer: 20140724Description: 109-18 p. digitalISSN:- 1029-2470
- Animals
- Antihypertensive Agents -- pharmacology
- Aorta -- metabolism
- Benzopyrans -- pharmacology
- Blood Pressure -- drug effects
- Cyclic GMP -- metabolism
- Cyclic N-Oxides -- pharmacology
- Drug Evaluation, Preclinical
- Drug Synergism
- Drug Therapy, Combination
- Ethanolamines -- pharmacology
- Free Radical Scavengers -- pharmacology
- Guanylate Cyclase -- metabolism
- Heart Rate -- drug effects
- Hypertension -- drug therapy
- Lipid Peroxidation
- Male
- NADPH Oxidases -- metabolism
- Nebivolol
- Nitric Oxide -- metabolism
- Nitric Oxide Synthase Type III -- metabolism
- Oxidative Stress
- Rats
- Rats, Sprague-Dawley
- Reactive Oxygen Species -- metabolism
- Second Messenger Systems
- Spin Labels
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.